Orthofix Medical (OFIX) Expected to Announce Quarterly Earnings on Tuesday

Orthofix Medical (NASDAQ:OFIX - Get Free Report) is anticipated to post its Q1 2025 quarterly earnings results before the market opens on Tuesday, May 6th. Analysts expect Orthofix Medical to post earnings of ($0.17) per share and revenue of $191.10 million for the quarter.

Orthofix Medical Stock Performance

Orthofix Medical stock traded up $0.24 during trading on Friday, reaching $13.79. The company had a trading volume of 160,277 shares, compared to its average volume of 254,725. The firm's 50-day simple moving average is $15.34 and its 200 day simple moving average is $17.04. Orthofix Medical has a 52 week low of $12.08 and a 52 week high of $20.73. The company has a current ratio of 2.39, a quick ratio of 1.11 and a debt-to-equity ratio of 0.25. The firm has a market capitalization of $538.11 million, a price-to-earnings ratio of -4.41 and a beta of 0.99.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on OFIX shares. Canaccord Genuity Group reissued a "buy" rating and issued a $24.00 target price on shares of Orthofix Medical in a report on Wednesday, February 26th. StockNews.com upgraded shares of Orthofix Medical from a "hold" rating to a "buy" rating in a research note on Tuesday, February 25th. Finally, Roth Mkm reiterated a "buy" rating and set a $22.00 target price on shares of Orthofix Medical in a research report on Wednesday, February 26th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus target price of $23.33.

Insider Activity at Orthofix Medical

In related news, insider Lucas Vitale sold 4,287 shares of the firm's stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $16.60, for a total value of $71,164.20. Following the completion of the transaction, the insider now directly owns 135,317 shares of the company's stock, valued at approximately $2,246,262.20. This trade represents a 3.07 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Jorge Andres Cedron sold 3,816 shares of the stock in a transaction on Wednesday, April 16th. The shares were sold at an average price of $13.31, for a total transaction of $50,790.96. Following the transaction, the insider now owns 42,500 shares of the company's stock, valued at $565,675. This trade represents a 8.24 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 9,242 shares of company stock valued at $141,710. Insiders own 2.60% of the company's stock.

About Orthofix Medical

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.